跳至主要内容
临床试验/NCT04793373
NCT04793373撤回不适用

Superiority of Epidural Placement Technique Using EpiFaith® Syringe Versus Conventional Glass Syringe in Laboring Paturients

Harvard Medical School (HMS and HSDM)2 个研究点 分布在 1 个国家开始时间: 2022年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
Success of epidural localization

研究概览

简要总结

The aim of this study is to evaluate the impact of EpiFaith® syringe on the establishment of successful epidural labor analgesia, change of elapsed time for identification of epidural space, and learning curve of CA-1 residents.

详细描述

We hypothesize that EpiFaith® syringe, in comparison with conventional glass syringe, will result in a similar overall success rate for catheter placement, but with a larger reduction in change of elapsed time for identification of epidural space and catheter placement of each practitioner. Moreover, we hypothesize that the cumulative learning summary curve using EpiFaith® syringe will be higher than conventional glass syringe in resident trainees, which will show the possible value of EpiFaith® syringe for teaching and learning obstetric epidural anesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Females 18 years of age and older at screening
  • Request labor epidural analgesia
  • Able to give informed consent to participate in the study
  • American Society of Anesthesiologists (ASA) class Ⅰ to Ⅲ health status
  • BMI ≤ 40 kg/m2

排除标准

  • BMI > 40 kg/m2; any contraindication to neuraxial anesthesia (coagulopathy, uncorrected hypovolemia, increased intracranial pressure, or local skin infection)
  • Cardiac disease history, marked spinal deformity, previous spinal surgery, or impalpable anatomical landmarks
  • Any allergy to bupivacaine or fentanyl

结局指标

主要结局

Success of epidural localization

时间窗: 30 minutes

Defined as the catheter can be inserted into epidural space successfully; no occurence of inadvertent dural puncture

次要结局

未报告次要终点

研究者

发起方
Harvard Medical School (HMS and HSDM)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jie Zhou

Assistant Professor

Harvard Medical School (HMS and HSDM)

研究点 (2)

Loading locations...

相似试验